OAT PINs and DINs

The tables below provide Product Identification Numbers (PINs) and Drug Identification Numbers (DINs) for PharmaCare claims for opioid agonist treatment (OAT). PINs listed are for OAT claims only.

For more information on OAT and current methadone formulations, please see the BC Centre on Substance Use bulletin (PDF, 480 KB).

On this page:


Interaction fees

For all eligible direct interaction OAT claims, PharmaCare pays an interaction fee to pharmacies that are:

  • Enrolled in the Methadone Maintenance Sub-Class; and
  • Dispensing methadone with direct interaction

Plan B claims are excluded from interaction fees. Eligible claims include those for Fair PharmaCare beneficiaries who have not met their deductible.


Pain indications

Many of the drugs listed below may be prescribed for pain. If a prescription is for pain, enter the transaction in PharmaNet with the corresponding DIN.

Do not use OAT PINs for pain indications.

Direct interaction
Drug PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose
10 mg/mL (cherry)
66999997 Plans B, C, G, P, W and Fair PharmaCare.

Maximum one dispensing fee and one interaction fee per patient per day.
  • Claim quantity must be submitted as total mLs.
  • SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.)
  • SIG must include the start and end dates of the prescription.
  • Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
  • Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
  • A single interaction fee will be paid for the first witnessed dose.
Metadol-D®
10 mg/mL (unflavoured)
67000005
methadone (Sterinova®)
10 mg/mL
67000017
Direct interaction with delivery
Drug PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose
10 mg/mL (cherry)
66999999 Plans B, C, G, P, W and Fair PharmaCare.

Maximum one dispensing fee and one interaction fee per patient per day.
  • Claim quantity must be submitted as total mLs.
  • SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.)
  • SIG must include the start and end dates of the prescription.
  • Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
  • Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
  • A single interaction fee will be paid for the first witnessed dose.
Metadol-D®
10 mg/mL (unflavoured)
67000007
methadone (Sterinova®)
10 mg/mL
67000018
No direct interaction
Drug PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose
10 mg/mL (cherry)
66999998 Plans B, C, G, P, W and Fair PharmaCare.
  • Claim quantity must be submitted as total mLs.
  • SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.)
  • SIG must include the start and end dates of the prescription.
  • Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
  • Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
Metadol-D®
10 mg/mL (unflavoured)
67000006
methadone (Sterinova®)
10 mg/mL
67000020
No direct interaction with delivery
Drug PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose
10 mg/mL (cherry)
67000000 Plans B, C, G, P, W and Fair PharmaCare.
  • Claim quantity must be submitted as total mLs.
  • SIG must include dose in mg and mL (e.g., Take 5 mLs (50 mg) once daily.)
  • SIG must include the start and end dates of the prescription.
  • Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.
  • Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.
Metadol-D®
10 mg/mL (unflavoured)
67000008
methadone (Sterinova®)
10 mg/mL
67000019
Non-benefit methadone
Drug PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose™ 10 mg/mL sugar-free
with direct interaction
67000001 Non-benefit. Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare. See relevant dispense type above for submission requirements.
Methadose™ 10 mg/mL sugar-free
delivery with direct interaction
67000003
Methadose™ 10 mg/mL sugar-free
without direct interaction
67000002
Methadose™ 10 mg/mL sugar-free
delivery without direct interaction
67000004
Compounded methadone 10 mg/mL
with direct interaction
67000013 Non-benefit. Last-resort, exceptional coverage only. Special Authority required.

Dispensing pharmacies must order compounded methadone from the central compounding pharmacy.

Please contact the BCCSU or the BCPhA for details.
See relevant dispense type above for submission requirements.
Compounded methadone 10 mg/mL
delivery with direct interaction
67000014
Compounded methadone 10 mg/mL
without direct interaction
67000016
Compounded methadone 10 mg/mL
delivery without direct interaction
67000015
Buprenorphine/naloxone, suboxone, and Kadian® DINs and PINs
Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements
buprenorphine/naloxone SL
2 mg/0.5 mg generics
ACT 02453908 Covered under plans B, C, G, P, W, and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.
  • Claim quantity must be submitted as the number of tablets.
  • SIG should include start and end dates as best practice (not mandatory).
PMS 02424851
buprenorphine/naloxone SL
8 mg/2 mg generics
ACT 02453916
PMS 02424878
Suboxone® buprenorphine/naloxone
2 mg/0.5 mg SL
02295695 Suboxone® is a partial benefit under plans B, C, G, P, W, and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.
  • Claim quantity must be submitted as the number of tablets.
  • SIG should include start and end dates as best practice (not mandatory).
Suboxone® buprenorphine/naloxone
8 mg/2 mg SL
02295709
Suboxone® buprenorphine/naloxone
12 mg/3 mg SL
02468085 Exceptional Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.
Suboxone® buprenorphine/naloxone
16 mg/4 mg SL
02468093
Kadian® slow-release oral morphine 10 mg capsule 22123349 (PIN) Covered for OAT under plans B, C, G, P, W and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.
  • Submit using PharmaCare PINs if for OAT.
  • Claim quantity must be submitted as the number of capsules.
  • SIG should include start and end dates as best practice (not mandatory).
Kadian® slow-release oral morphine 20 mg capsule 22123346 (PIN)
Kadian® slow-release oral morphine 50 mg capsule 22123347 (PIN)
Kadian® slow-release oral morphine 100 mg capsule 22123348 (PIN)

Injectable opioid agonist treatment (iOAT)